Aktis Has First Biotech IPO of 2026, Raising $318M to Expand the Reach of Radiopharmaceuticals
For all of the benefit that radiopharmaceuticals offer, these treatments currently address a limited number of cancer targets. Aktis Oncology ...
For all of the benefit that radiopharmaceuticals offer, these treatments currently address a limited number of cancer targets. Aktis Oncology ...
Digital solutions have greatly expanded access to mental health support, though they’re not always reaching the people who need it ...
MAN v FAT member Liam Gillmore, from our Tonbridge club, has managed to lose 30kg since joining in December of ...
Maria stared at her laptop screen, a sigh escaping her lips. Her friend, beaming from a post-workout selfie, was raving ...
Sanofi is shelling out $1.15 billion to acquire Vicebio, a startup with a pipeline of respiratory vaccine candidates and a ...
US flu activity declined steadily again last week, with rates of influenza-like illness (ILI) dropping further and staying below baseline ...
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this weekend, ...
Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is ...
Using RNA to interfere with a gene’s expression of disease-causing proteins is a validated therapeutic approach, but so far, the ...
Ready to take your fitness journey to the next level? Strength training is one of the most powerful ways to ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.